You are hereHome
- KEYNOTE SPEAKER
- PLENARY SPEAKERS
- E-POSTER SUBMISSION
Toronto General Hospital Research Institute (TGHRI) is excited to announce its annual Research Day, to be held in person on Wednesday, October 18, 2023. This year’s theme will be "Aligning Basic and Clinical Research".
This event is a celebration of TGHRI achievements in basic and clinical research and is an opportunity to promote interdepartmental collaborations among researchers. TGHRI Research Day is open to all TGHRI Scientists, Clinician Scientists, trainees and staff. In addition to the keynote presentation and presentations by TGHRI Scientists featuring their ongoing research, participants will learn about the ongoing research at TGHRI through trainee poster presentations. As in previous years, the first round of poster judging will take place prior to Research Day. TGHRI faculty and leadership team will grade the posters and audio presentations online. The highest ranked presentations will be asked to give a 1-min flash presentation of their work during Research Day, and the winners will be presented with an award. Posters and audio presentations will be available for online viewing starting October 13. Please see the agenda tab for details regarding the in-person poster presentation schedule.
Now - Sept 29:
Aug 30 - Sept 20:
VoiceThread website opens for e-Poster and 5-min voiceover presentation submission. The e-Poster template can be found here.
e-Poster and 5-min voiceover presentation submission due
Sept 25 - Oct 4:
VoiceThread website opens for poster judges to evaluate work
Poster judges' evaluations due
Selected 1-min flash presenters notified
Oct 13 - 31:
VoiceThread website opens to all viewers
Brian Golden, MS, PhD, FCAHS
Sandra Rotman Chaired Professor of Health Sector Strategy
Professor of Strategic Management
Academic Director, Sandra Rotman Centre for Health Sector Strategy
The Rotman School of Management & Faculty of Public Health
The University of Toronto
Professor Brian Golden (PhD, Kellogg School of Management, Northwestern University) is the Sandra Rotman Chaired Professor in Health Sector Strategy at the Rotman School of Management, The University of Toronto. He is Academic Director of Rotman’s Global Executive MBA and Rotman’s Global Executive MBA in Healthcare and The Life Sciences. He previously served as Vice-Dean Professional Programs and Vice-Dean MBA Programs.
Professor Golden was a member of the advisory committee that led to the creation of Ontario’s Excellent Care for All legislation. In 2013 he co-authored the province’s report on Primary Care Governance, and in 2015 co-authored “Patient Care Groups: A new model of population based primary health care for Ontario” (the “Price Report”) for the Ministry of Health. Professor Golden was Board Chair of the Institute for Clinical Evaluative Sciences (ICES).
Professor Golden conducts research, teaches and consults in the areas of change management, leadership, incentives and payment models, system design and governance. Among his published work are articles in The Harvard Business Review, The Canadian Medical Association Journal, The Strategic Management Journal, Healthcare Quarterly, Healthcare Papers, The Annals of Pharmacotherapy, Management Science, Clinical Oncology, and Health Policy. Professor Golden’s article “Transforming Healthcare Organizations” in Healthcare Quarterly has been that publication’s most downloaded article with over 200,000 downloads.
As an advisor and director of leadership development programs, Professor Golden has worked with a variety of organizations including Ontario’s Ministry of Health, several Medical Associations in Canada, Britain’s National Health Service, health regions across Canada, and hospitals including The Hospital for Sick Children, The University Health Network, Hamilton Health Sciences, London Health Science Centre, Sunnybrook College Health Sciences Centre, The Centre for Addiction and Mental Health, British Columbia Cancer Agency, The King Faisal Specialist Hospital, and Baylor Medical Center. Private sector clients include Tieto (Finland), General Electric, Janssen-Ortho, Philips and Baxter.
His honours include Canada’s Ted Freedman Innovation in Healthcare Education Award and the Canadian Medical Association’s first Eureka Award for Innovation in Physician Education. In 2016 he was made a Fellow of the Canadian Academy of Health Sciences.
Kate Hanneman, MD, MPH, FRCPC
Dr. Hanneman is an Associate Professor at the University of Toronto and a Clinician Scientist at the Toronto General Hospital Research Institute. She is the Director of Cardiac Imaging Research at the Joint Department of Medical Imaging and the Medical Imaging Site Director at Women’s College Hospital. Dr. Hanneman is an Associate Editor and Chair of the Radiology: Cardiothoracic Imaging Trainee Editorial Board. She has received grant funding as principal investigator from the Canadian Institute of Health Research and leads an active research program focused on improving health outcomes for patients with cardiomyopathies using cardiac imaging.
Adam Gehring, PhD
Dr. Gehring is the Biology Lead and Senior Scientist at the Toronto Center for Liver Disease and Associate Professor in the Department of Immunology at the University of Toronto. He runs a translational, human HBV immunology research lab focused on liver pathogenesis and sex-based differences in disease progression. His primary interest lies in defining the mechanisms driving liver inflammation during HBV-related flares using functional and transcriptomic approaches in liver biopsies. He also runs an immune monitoring lab for the Toronto Centre for Liver Disease to process and analyze immune responses in Phase 1/2 clinical studies for novel therapeutic agents targeting HBV.
Heather Reich, MD CM, PhD, FRCP(C)
Dr. Reich is the Oreopoulos-Baxter Division Director of Nephrology at the Department of Medicine of University of Toronto. She is a clinician-scientist and holds the Gabor Zellerman Chair in Nephrology Research. Dr. Reich directs the glomerulonephritis program at Toronto General Hospital. This program spans clinical care of patients with glomerulonephritis, contribution to innovative clinical trials and translational research. She has previously served as the co-director of the annual educational pre-course in glomerulonephritis for the American Society of Nephrology, and contributed to the 2021 ISN-KDIGO guidelines for the treatment of glomerulonephritis.
Kumaraswamy Nanthakumar, MD, FRCPC
Dr. Nanthakumar is a Cardiologist and Cardiac Electrophysiologist at Toronto General Hospital where he served as Director of Heart Rhythm Disorders for a decade. He is full Professor of Medicine, University of Toronto and Senior Scientist at the Toronto General Hospital Research Institute. He is a dedicated teacher, passionate in training and mentoring future electrophysiologists both locally and internationally. He holds global acclaim in intracardiac mapping with DeEP, Omnipolar, and Repolarisation mapping among his fields of expertise. He has published over 200 original peer-reviewed journal articles, cited over 5,300 times. He is also an innovator at Techna He has been granted multiple intellectual properties and is involved in commercializing these IP.
His medical education and training were mainly at University of Toronto starting in 1991. He completed medical school at University of Toronto in 1995. Completed additional 6 years of postgraduate training in Internal Medicine and Cardiology at University of Toronto. He subsequently completed a further 3 year sub specialization training cardiac electrophysiology at the University of Alabama at Birmingham, where he studied the mechanisms of cardiac arrhythmias and built expertise in cardiac mapping. His clinical expertise is focused on devices in heart failure and performing catheter ablation of ventricular tachycardia and supra ventricular tachycardias.
Andrew Sage, PhD
Dr. Sage is an Assistant Scientist with the Toronto Lung Transplant Program at the Toronto General Hospital Research Institute and an Assistant Professor at the University of Toronto in Ontario, Canada. His research is focused on identifying and translating novel biomarkers and medical devices to aid in surgical decision-making during lung transplantation. He has a keen interest in cutting-edge technologies such as machine learning and artificial intelligence as well as remote piloted aircrafts. In 2021 Dr. Sage was part of the team that completed the world's first delivery of a human lung for transplant via drone in downtown Toronto. Prior to joining the Toronto Lung Transplant Program, Dr. Sage completed a PhD at the University of Toronto in Pharmaceutical Sciences and an MSc and BSc in Biochemistry at McMaster University and Queen's University.
Golnaz Karoubi, PhD
Dr. Golnaz Karoubi is Assistant Scientist at the Toronto General Hospital Research Institute and principal investigator in the Latner Thoracic Research Labs. She currently holds an Assistant Professor appointment in the department of Laboratory Medicine and Pathobiology and a cross-appointment in the department of Mechanical and Industrial Engineering at the University of Toronto. Dr. Karoubi received her PhD in Applied Science and Engineering at the University of Toronto and joined the Lung Regenerative Medicine Program in the Department of Clinical Research in Berne University, Switzerland for a post-doctoral research fellowship. She stayed on as a Group Leader in 2008 to direct the basic and transitional science as related to Cancer Stem Cell and Lung Regenerative Medicine in the Department of Biomedical Research at the University of Berne until 2012. In early 2012, she joined the team of Dr. Tom Waddell at the Toronto General Hospital Research Institute as a Senior Scientific Associate and was appointed to Assistant Scientist at the Toronto General Hospital Research Institute (University Health Network) in November 2019 and to Assistant Professor in the Department of Laboratory Medicine and Pathobiology in July 2020. She is the recipient of the Di Poce Research Scholar Award for Women in Transplantation. Her research interests include development of practical approaches for treatment of lung and airway disease. Studies focus on: (1) Lung, tracheal and airway regeneration; (2) Use of pluripotent derived airway epithelial cells for tissue engineering applications; and (3) cell-based therapeutic approaches for end-stage lung disease.
E-Poster submission is now closed